Medmen Enterprises Class Stock Current Valuation
| MMNFFDelisted Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Medmen Enterprises Class helps investors to measure Medmen Enterprises' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Medmen Enterprises' price fluctuation is very steady at this time. Calculation of the real value of Medmen Enterprises Class is based on 3 months time horizon. Increasing Medmen Enterprises' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medmen otc stock is determined by what a typical buyer is willing to pay for full or partial control of Medmen Enterprises Class. Since Medmen Enterprises is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medmen OTC Stock. However, Medmen Enterprises' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 6.4E-5 | Hype 1.0E-4 | Naive 9.6E-5 |
The real value of Medmen OTC Stock, also known as its intrinsic value, is the underlying worth of Medmen Enterprises Class OTC Stock, which is reflected in its stock price. It is based on Medmen Enterprises' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medmen Enterprises' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medmen Enterprises Class helps investors to forecast how Medmen otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medmen Enterprises more accurately as focusing exclusively on Medmen Enterprises' fundamentals will not take into account other important factors: Medmen Enterprises Class OTC Stock Current Valuation Analysis
Medmen Enterprises' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medmen Enterprises Current Valuation | 390.25 M |
Most of Medmen Enterprises' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medmen Enterprises Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Medmen Enterprises Class has a Current Valuation of 390.25 M. This is 97.28% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 97.65% higher than that of the company.
Medmen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medmen Enterprises' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medmen Enterprises could also be used in its relative valuation, which is a method of valuing Medmen Enterprises by comparing valuation metrics of similar companies.Medmen Enterprises is currently under evaluation in current valuation category among its peers.
Medmen Fundamentals
| Return On Asset | -0.0522 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 390.25 M | |||
| Shares Outstanding | 1.3 B | |||
| Shares Owned By Insiders | 10.98 % | |||
| Shares Owned By Institutions | 2.97 % | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 140.81 M | |||
| Gross Profit | 69.73 M | |||
| EBITDA | (106.73 M) | |||
| Net Income | (195.19 M) | |||
| Cash And Equivalents | 13.53 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 206.38 M | |||
| Debt To Equity | 7.54 % | |||
| Current Ratio | 0.50 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (62.53 M) | |||
| Earnings Per Share | (0.14) X | |||
| Target Price | 0.32 | |||
| Number Of Employees | 428 | |||
| Beta | 1.93 | |||
| Market Capitalization | 36.33 M | |||
| Total Asset | 323.22 M | |||
| Net Asset | 323.22 M |
About Medmen Enterprises Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medmen Enterprises Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medmen Enterprises using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medmen Enterprises Class based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |